Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Tenofovir Alafenamide and Its Combination Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Tenofovir Alafenamide 1.4.3 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide 1.4.4 Emtricitabine/Rilpivirine/Tenofovir Alafenamide 1.4.5 Emtricitabine/Renofovir Alafenamide 1.4.6 Bictegravir/Emtricitabine/Tenofovir Alafenamide 1.5 Market by Application 1.5.1 Global Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Drug Center 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Tenofovir Alafenamide and Its Combination Drugs Market Size 2.2 Tenofovir Alafenamide and Its Combination Drugs Growth Trends by Regions 2.2.1 Tenofovir Alafenamide and Its Combination Drugs Market Size by Regions (2014-2025) 2.2.2 Tenofovir Alafenamide and Its Combination Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Tenofovir Alafenamide and Its Combination Drugs Market Size by by Players 3.1.1 Global Tenofovir Alafenamide and Its Combination Drugs Revenue by by Players (2014-2019) 3.1.2 Global Tenofovir Alafenamide and Its Combination Drugs Revenue Market Share by by Players (2014-2019) 3.1.3 Global Tenofovir Alafenamide and Its Combination Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Tenofovir Alafenamide and Its Combination Drugs Key Players Head office and Area Served 3.3 Key Players Tenofovir Alafenamide and Its Combination Drugs Product/Solution/Service 3.4 Date of Enter into Tenofovir Alafenamide and Its Combination Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) 4.2 Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) 5 United States 5.1 United States Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 5.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in United States 5.3 United States Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 5.4 United States Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 6 Europe 6.1 Europe Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 6.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in Europe 6.3 Europe Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 6.4 Europe Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 7 China 7.1 China Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 7.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in China 7.3 China Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 7.4 China Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 8 Japan 8.1 Japan Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 8.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in Japan 8.3 Japan Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 8.4 Japan Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 9.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in Southeast Asia 9.3 Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 9.4 Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 10 India 10.1 India Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 10.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in India 10.3 India Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 10.4 India Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size (2014-2019) 11.2 Tenofovir Alafenamide and Its Combination Drugs Key Players in Central & South America 11.3 Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size by Type 11.4 Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size by Application 12 International Players Profiles 12.1 Affine Formulations Limited 12.1.1 Affine Formulations Limited Company Details 12.1.2 Company Description and Business Overview 12.1.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.1.4 Affine Formulations Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.1.5 Affine Formulations Limited Recent Development 12.2 Beacon Pharmaceuticals 12.2.1 Beacon Pharmaceuticals Company Details 12.2.2 Company Description and Business Overview 12.2.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.2.4 Beacon Pharmaceuticals Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.2.5 Beacon Pharmaceuticals Recent Development 12.3 Biocon Limited 12.3.1 Biocon Limited Company Details 12.3.2 Company Description and Business Overview 12.3.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.3.4 Biocon Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.3.5 Biocon Limited Recent Development 12.4 Cipla 12.4.1 Cipla Company Details 12.4.2 Company Description and Business Overview 12.4.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.4.4 Cipla Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.4.5 Cipla Recent Development 12.5 Flamingo Pharmaceuticals Limited 12.5.1 Flamingo Pharmaceuticals Limited Company Details 12.5.2 Company Description and Business Overview 12.5.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.5.4 Flamingo Pharmaceuticals Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.5.5 Flamingo Pharmaceuticals Limited Recent Development 12.6 Gilead Sciences 12.6.1 Gilead Sciences Company Details 12.6.2 Company Description and Business Overview 12.6.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.6.4 Gilead Sciences Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.6.5 Gilead Sciences Recent Development 12.7 IPCA Laboratories 12.7.1 IPCA Laboratories Company Details 12.7.2 Company Description and Business Overview 12.7.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.7.4 IPCA Laboratories Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.7.5 IPCA Laboratories Recent Development 12.8 Johnson and Johnson 12.8.1 Johnson and Johnson Company Details 12.8.2 Company Description and Business Overview 12.8.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.8.4 Johnson and Johnson Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.8.5 Johnson and Johnson Recent Development 12.9 Julphar Bangladesh 12.9.1 Julphar Bangladesh Company Details 12.9.2 Company Description and Business Overview 12.9.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.9.4 Julphar Bangladesh Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.9.5 Julphar Bangladesh Recent Development 12.10 Medisist Pharma 12.10.1 Medisist Pharma Company Details 12.10.2 Company Description and Business Overview 12.10.3 Tenofovir Alafenamide and Its Combination Drugs Introduction 12.10.4 Medisist Pharma Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) 12.10.5 Medisist Pharma Recent Development 12.11 Mylan Pharmaceuticals 12.12 Natco Pharma 12.13 Sun Pharmaceutical Industries 12.14 CHIA TAI TIANQING (CTTQ) Pharmaceutical 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Tenofovir Alafenamide and Its Combination Drugs Key Market Segments Table Key Players Tenofovir Alafenamide and Its Combination Drugs Covered Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Share by TypeType in 2018 & 2025 Figure Tenofovir Alafenamide Figures Table Key Players of Tenofovir Alafenamide Figure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Figures Table Key Players of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Figure Emtricitabine/Rilpivirine/Tenofovir Alafenamide Figures Table Key Players of Emtricitabine/Rilpivirine/Tenofovir Alafenamide Figure Emtricitabine/Renofovir Alafenamide Figures Table Key Players of Emtricitabine/Renofovir Alafenamide Figure Bictegravir/Emtricitabine/Tenofovir Alafenamide Figures Table Key Players of Bictegravir/Emtricitabine/Tenofovir Alafenamide Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size Growth by Application 2019-2025 (Million US$) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinic Case Studies Figure Drug Center Case Studies Figure Other Case Studies Figure Tenofovir Alafenamide and Its Combination Drugs Report Years Considered Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2025 (Million US$) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Share by Regions 2014-2019 Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Share by Regions 2014-2019 Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Tenofovir Alafenamide and Its Combination Drugs Revenue by by Players (2014-2019) (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Share by by Players (2014-2019) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Share by by Players in 2018 Table Global Tenofovir Alafenamide and Its Combination Drugs by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Tenofovir Alafenamide and Its Combination Drugs Product/Solution/Service Table Date of Enter into Tenofovir Alafenamide and Its Combination Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size Share by Type (2014-2019) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size Market Share by Type (2014-2019) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size Share by Application (2014-2019) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size Market Share by Application (2014-2019) Figure Global Tenofovir Alafenamide and Its Combination Drugs Revenue Market Share by Application in 2018 Figure United States Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table United States Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table United States Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table United States Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table United States Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table United States Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table United States Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure Europe Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table Europe Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table Europe Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table Europe Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table Europe Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure China Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table China Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table China Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table China Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table China Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table China Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table China Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure Japan Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table Japan Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table Japan Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table Japan Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table Japan Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure India Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table India Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table India Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table India Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table India Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table India Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table India Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Figure Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Tenofovir Alafenamide and Its Combination Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Tenofovir Alafenamide and Its Combination Drugs Market Share (2018-2019) Table Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size by Type (2014-2019) (Million US$) Table Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Share by Type (2014-2019) Table Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2014-2019) (Million US$) Table Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Share by Application (2014-2019) Table Affine Formulations Limited Company Details Table Affine Formulations Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) (Million US$) Figure Affine Formulations Limited Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Affine Formulations Limited Recent Development Table Beacon Pharmaceuticals Company Details Table Beacon Pharmaceuticals Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Beacon Pharmaceuticals Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Beacon Pharmaceuticals Recent Development Table Biocon Limited Company Details Table Biocon Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Biocon Limited Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Biocon Limited Recent Development Table Cipla Company Details Table Cipla Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Cipla Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Cipla Recent Development Table Flamingo Pharmaceuticals Limited Company Details Table Flamingo Pharmaceuticals Limited Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Flamingo Pharmaceuticals Limited Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Flamingo Pharmaceuticals Limited Recent Development Table Gilead Sciences Company Details Table Gilead Sciences Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Gilead Sciences Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Gilead Sciences Recent Development Table IPCA Laboratories Company Details Table IPCA Laboratories Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure IPCA Laboratories Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table IPCA Laboratories Recent Development Table Johnson and Johnson Company Details Table Johnson and Johnson Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Johnson and Johnson Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Johnson and Johnson Recent Development Table Julphar Bangladesh Company Details Table Julphar Bangladesh Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Julphar Bangladesh Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Julphar Bangladesh Recent Development Table Medisist Pharma Company Details Table Medisist Pharma Revenue in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019)(Million US$) Figure Medisist Pharma Revenue Growth Rate in Tenofovir Alafenamide and Its Combination Drugs Business (2014-2019) Table Medisist Pharma Recent Development Table Mylan Pharmaceuticals Company Details Table Natco Pharma Company Details Table Sun Pharmaceutical Industries Company Details Table CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Details Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size Share by Regions (2019-2025) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size Share by Regions in 2025 Figure United States Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Tenofovir Alafenamide and Its Combination Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Product (2019-2025) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Product in 2025 Table Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Application (2019-2025) Figure Global Tenofovir Alafenamide and Its Combination Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Affine Formulations Limited Beacon Pharmaceuticals Biocon Limited Cipla Flamingo Pharmaceuticals Limited Gilead Sciences IPCA Laboratories Johnson and Johnson Julphar Bangladesh Medisist Pharma Mylan Pharmaceuticals Natco Pharma Sun Pharmaceutical Industries CHIA TAI TIANQING (CTTQ) Pharmaceutical